Whereas, activation of AMPK signaling also inhibits mTOR/HIF-1α signaling and the glycolysis-dependent metabolism in tamoxifen resistant breast cancer cells (Woo, et al., 2015). The gene discussed is HIF1A; the disease is breast carcinoma.